Brian Thiessen

A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation

Suzanne Kamel-Reid, Peter Forsyth, W. Mason, 2009, Cancer Chemotherapy and Pharmacology.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma

Brigitta G. Baumert, Jaap C. Reijneveld, Andreas von Deimling, 2016, The Lancet. Oncology.

Evaluation of Early Response to SU101 Target-based Therapy in Patients with Recurrent Supratentorial Malignant Gliomas Using FDG PET and Gd-DTPA MRI

Bradley J. Beattie, Andrei G. Vlassenko, Ronald G. Blasberg, 2004, Journal of Neuro-Oncology.